Ticagrelor

Overview

Ticagrelor is an oral antiplatelet agent that belongs to the class of cyclopentyltriazolopyrimidines, used to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome or myocardial infarction. It works by reversibly inhibiting the P2Y12 receptor, preventing platelet activation and aggregation.

API suppliers (35)

Suppliers of Ticagrelor evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
• ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• HONOUR LAB LTDIndia1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• LEK PHARMACEUTICALS DD1 active DMF GMP on record
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF GMP on record
• Micro Labs Usa1 active DMF
• RAKS PHARMA PVT LTDIndia1 active DMF
• WUHAN ZY PHARMACEUTICAL CO LTD1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
• Jiangxi Synergy Pharmaceutical Co., LtdChina1 active DMF
• JUBILANT BIOSYS LTDIndia1 active DMF
• PHARMARESOURCES (KAIYUAN) CO LTD1 active DMF
• Unichem Laboratories Ltd.India1 active DMF GMP on record
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• Sichuan Qingmu Pharmaceutical Co., Ltd.China1 active DMF
• COHANCE LIFESCIENCES LTDIndia1 active DMF GMP on record
• MSN Organics Private LimitedIndia1 active DMF
• USV PRIVATE LTDIndia1 active DMF GMP on record
• INNOVARE LABS PRIVATE LTDIndia1 active DMF
• Divis LaboratoriesIndia1 active DMF GMP on record
• Mankind Pharma LimitedIndia1 active DMF GMP on record
• Shanghai Huilun Pharmaceutical Co., Ltd.China1 active DMF

Showing 25 of 35 suppliers — see the full list in the app.

EU CEP holders (23)

Companies holding a valid EU Certificate of Suitability (CEP) for Ticagrelor, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (38 approved US products), the latest listed US patent on Ticagrelor expires 27 Jul 2036. Generic API sourcing typically opens up once these lapse.

Therapeutic areas